[Proliferative vitreoretinopathy: pathogenetic factors and development peculiarities].
Krivosheina
O I
OI
D000818:Animals; D016207:Cytokines / Q000502:physiology; D004195:Disease Models, Animal; D004285:Dogs; D005346:Fibroblast Growth Factors / Q000502:physiology; D006706:Homeostasis; D006801:Humans; D007136:Immunoglobulins / Q000276:immunology; D007150:Immunohistochemistry; D010982:Platelet-Derived Growth Factor / Q000502:physiology; D011379:Prognosis; D013601:T-Lymphocytes / Q000276:immunology; D014409:Tumor Necrosis Factor-alpha / Q000502:physiology; D042461:Vascular Endothelial Growth Factor A / Q000502:physiology; D018630:Vitreoretinopathy, Proliferative / Q000175:diagnosis / Q000209:etiology* / Q000276:immunology / Q000473:pathology / Q000503:physiopathology
D016207:Cytokines; D007136:Immunoglobulins; D010982:Platelet-Derived Growth Factor; D014409:Tumor Necrosis Factor-alpha; D042461:Vascular Endothelial Growth Factor A; D005346:Fibroblast Growth Factors